A round-table discussion to clarify the role of the long-acting muscarinic antagonist tiotropium in line with recommendations from GOLD.
Information intended for healthcare professionals only. The round-table discussion meeting, and the development and printing of the supplement, have been developed in partnership with Teva UK Limited. In order to comply with the ABPI Code of Practice, Teva UK Limited has reviewed the supplement for factual accuracy, to ensure it is fair and balanced, and to ensure its compliance with appropriate regulations, MGP has paid the participant honoraria on behalf of Teva UK Limited. The views and opinions of the discussion group are not necessarily those of Teva UK Limited or of Guidelines in Practice, its publisher, advisers, or advertisers. No part of this publication may be reproduced in any form without the permission of the publisher.